We are live on ! Find out more
NFH

New Frontier Health Corporation Ordinary Shares

Delisted

NFH was delisted on the 26th of January, 2022.

2 hedge funds and large institutions have $208M invested in New Frontier Health Corporation Ordinary Shares in 2022 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 60 closing their positions.

New
Increased
Maintained
Reduced
Closed

75% less funds holding in top 10

Funds holding in top 10: 82 (-6)

76% less capital invested

Capital invested by funds: $864M → $208M (-$657M)

97% less funds holding

Funds holding: 622 (-60)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 60

Holders
2
Holders Change
-60
Holders Change %
-96.77%
% of All Funds
0.03%
Holding in Top 10
2
Holding in Top 10 Change
-6
Holding in Top 10 Change %
-75%
% of All Funds
0.03%
New
Increased
Reduced
Closed
60
Calls
Puts
Net Calls
Net Calls Change

NFH Hedge Fund Activity: Q1 2022 in Review

2 of the 6,360 institutional investors tracked by Wall St. Rank reported a position in New Frontier Health Corporation Ordinary Shares (NFH) for Q1 2022, worth a combined $208M — down 76% from $864M a quarter earlier.

Sellers outnumbered buyers: 60 funds closed out of NFH and 0 opened new positions — a net loss of 60 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Fosun International, exiting entirely with an estimated $108M sold.

  • 2 institutional investors held New Frontier Health Corporation Ordinary Shares (NFH) as of Q1 2022, down from 62 in Q4 2021.
  • Funds reported $208M of New Frontier Health Corporation Ordinary Shares stock for Q1 2022, down 76% quarter-over-quarter.
  • 0 funds opened new New Frontier Health Corporation Ordinary Shares positions in Q1 2022 and 60 closed out, a net change of -60 holders.
  • The largest New Frontier Health Corporation Ordinary Shares seller in Q1 2022 was Fosun International, an estimated $108M sold.

Based on aggregated 13F filings for Q1 2022.